Peptide Delivered by Nasal Spray Can Reduce Seizure Activity and Protect Neurons in Alzheimer’s and Epilepsy - Neuroscience News

A1R-CT, a novel peptide that binds to neurabin, can be administered via a nasal spray and holds the potential to interrupt uncontrollable brain activity associated with TBI, stroke, epilepsy, and Alzheimer's disease.

Summary: A1R-CT, a novel peptide that binds to neurabin, can be administered via a nasal spray and holds the potential to interrupt uncontrollable brain activity associated with TBI, stroke, epilepsy… [+9429 chars]

full article...